Response to Takeover Proposal
Lifeway Foods, Inc. (NASDAQ: LWAY), a prominent supplier of kefir and fermented probiotic products, has firmly rejected an unsolicited takeover offer from Danone North America PBC. The decision stems from a thorough analysis conducted by Lifeway's Board of Directors and their independent financial and legal advisors, indicating that the offer significantly undervalues the company's true worth.
Financial Performance Highlights
As part of Lifeway Foods' announcement, the company revealed that its preliminary fourth-quarter net sales are expected to fall between $45.1 million and $46.6 million. Additionally, projections for the entire year of 2024 indicate anticipated net sales between $185.0 million and $186.5 million, showcasing an impressive growth trajectory compared to $160.1 million in the previous year.
Commitment to Shareholder Value
Julie Smolyansky, the Chairwoman and CEO of Lifeway, expressed confidence in the company's strategy. She stated, "Danone's offer is inadequate, and while they attempt to pursue this opportunistic proposal, Lifeway is focused on delivering substantial value to our shareholders." The company's robust sales projections for 2024 highlight the effectiveness of its operational strategies.
Legal Matters Regarding Stockholder Agreements
Lifeway Foods has raised concerns regarding the 1999 Stockholder Agreement with Danone, asserting that it violates Illinois law. The company is prepared to pursue all possible legal remedies to nullify this agreement, which it believes was invalid from its inception. The Board's commitment to uphold the law demonstrates Lifeway's dedication to ensuring its shareholders' best interests.
Steady Growth and Market Position
Under Smolyansky's leadership, Lifeway has experienced remarkable growth, achieving 21 consecutive quarters of revenue increase. The company reported double-digit year-over-year revenue growth in Q3 2024 and has delivered impressive shareholder returns of 788% and 270% over the past five and three years, significantly surpassing the performance of key competitors and major stock indices.
Strategic Assessment Moving Forward
In light of Danone's unsolicited proposal, Lifeway's management and external advisors are evaluating the dynamics of their relationship with Danone. This careful assessment aims to protect the company's interests as well as those of its shareholders, ensuring that the company's future growth remains a priority.
About Lifeway Foods, Inc.
Lifeway Foods, Inc. is recognized as America’s leading supplier of the probiotic fermented beverage known as kefir. Beyond its line of drinkable kefir, the company also offers a diverse range of cheese products and a ProBugs line specifically designed for children. Lifeway’s flavorful and nutritious fermented dairy products are now widely available across the U.S. and several international markets.
Frequently Asked Questions
What led Lifeway Foods to reject Danone's takeover offer?
Lifeway Foods' Board determined that Danone's offer significantly undervalued the company based on expert analyses, prompting a rejection.
What are Lifeway's projected sales figures for 2024?
The projections indicate that Lifeway expects to achieve net sales between $185.0 million and $186.5 million in 2024, demonstrating strong growth.
How has Lifeway performed in terms of growth?
Lifeway has shown impressive growth with 21 consecutive quarters of revenue increases and remarkable returns for shareholders over the last few years.
What legal concerns does Lifeway have with the 1999 Stockholder Agreement?
Lifeway believes that the 1999 Stockholder Agreement with Danone violates Illinois law and is taking steps to nullify it as part of protecting its interests.
What is Lifeway Foods' market focus?
Lifeway focuses on producing kefir and other fermented probiotic products, emphasizing health benefits and appealing to a broad consumer base in various markets.
